Sephora to fight against racial bias with an action plan
newsnews usbusiness financetype-text
January 13, 2021
Beauty retailer Sephora plans to increase the diversity in its product offerings and offer more inclusive marketing as part of a wide-reaching plan to combat racially biased experiences and unfair treatment for its customers.
United Parcel Service Inc. is responding to the growth in online shopping and pressures for speedy delivery by seeking to expand its drone deliveries and adding thousands of new spots where customers can pick up packages. The Atlanta-based package delivery giant said Tuesday it is adding 12,000 new package pickup locations inside CVS, The Michaels Co. and Advance Auto Parts stores.
Facebook's Instagram is officially launching its answer to the hit short video app TikTok — Instagram Reels. The new Instagram feature will let users record and edit 15-second videos with audio, and will let users add visual effects. Users will be able to share Reels with followers in Instagram in a dedicated section called Reels in Explore, or in the Story feature where posts disappear after 24 hours.
Boeing will make standard on its troubled new airliner a safety feature that might have helped the crew of a jet that crashed shortly after takeoff last year in Indonesia, killing everyone on board. The equipment, which had been offered as an option, alerts pilots of faulty information from key sensors. It will now be included on every 737 Max as part of changes that Boeing is rushing to complete on the jets by early next week, according to two people familiar with the changes.
After three months of near total blackout of cinemas nationwide, movie theaters are preparing to reopen — even if it means only a few titles on the marquee and showings limited to as little as 25% capacity. AMC Theaters, the world's largest theater operator, said Tuesday that it expects to have 97-98% of its theaters worldwide reopened by mid-July.
Massachusetts has brought a lawsuit accusing members of the Sackler family, owners of the pharmaceutical company that produces OxyContin, of deceiving patients and doctors about the risks of the addictive drug — complicating the family's established philanthropic legacy.